share_log

HC Wainwright & Co. Maintains Buy on BioAtla, Lowers Price Target to $10

HC Wainwright & Co. Maintains Buy on BioAtla, Lowers Price Target to $10

HC Wainwright & Co.維持對BioAtla的買入,將目標價下調至10美元
Benzinga ·  2023/11/08 08:11

HC Wainwright & Co. analyst Arthur He maintains BioAtla (NASDAQ:BCAB) with a Buy and lowers the price target from $17 to $10.

HC Wainwright & Co. 分析師亞瑟·何維持BioAtla(納斯達克股票代碼:BCAB)的買入,並將目標股價從17美元下調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論